Moreover, the clinicopathological correlation analysis revealed that low expression of TUSC8 was significantly associated with aggressive tumor behavior in large tumor size, tumor encapsulation, venous invasion and advanced TNM staging of breast cancer patients. Here, TUSC8 is linked to breast carcinoma.